Gepirone vs Placebo in Treatment of Cocaine Dependence - 3

University of Pennsylvania

Status and phase: Completed; Phase 2

Conditions: Cocaine-Related Disorders

Treatments: Drug: Gepirone

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000189

K20-00144-3

NIDA-00144-3

3R01DA012268 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to test antidepressant medication, gepirone, as a pharmacotherapy for cocaine dependent subjects.

Enrollment: 41 patients

Sex: Male

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind